Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) Interest Expenses (2020 - 2025)

Historic Interest Expenses for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $919000.0.

  • PROCEPT BioRobotics' Interest Expenses fell 1938.6% to $919000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 million, marking a year-over-year decrease of 1566.82%. This contributed to the annual value of $4.2 million for FY2024, which is 473.09% up from last year.
  • Per PROCEPT BioRobotics' latest filing, its Interest Expenses stood at $919000.0 for Q3 2025, which was down 1938.6% from $895000.0 recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Interest Expenses ranged from a high of $1.5 million in Q3 2021 and a low of $866000.0 during Q4 2022
  • Moreover, its 5-year median value for Interest Expenses was $1.0 million (2024), whereas its average is $1.2 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first tumbled by 3986.11% in 2022, then surged by 2990.76% in 2023.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Interest Expenses stood at $1.4 million in 2021, then plummeted by 39.86% to $866000.0 in 2022, then increased by 29.91% to $1.1 million in 2023, then dropped by 13.87% to $969000.0 in 2024, then decreased by 5.16% to $919000.0 in 2025.
  • Its last three reported values are $919000.0 in Q3 2025, $895000.0 for Q2 2025, and $877000.0 during Q1 2025.